New Consesus on Botulinum Toxin Application in Treatment of Cerebral Palsy
DOI:
https://doi.org/10.5457/ams.v39i1%20Suppl..193Keywords:
cerebral palsy, Botulinum toxinAbstract
Cerebral palsy (CP) is a most common cause of spastic movement disorders with children. One of methods of treating spasticity is application of Botulinum toxin (BoNT). BoNT therapy has widely been used for 20 years now during which time it has proven to be a safe treatment. Botulinum toxin is natural purified protein and the strongest biological toxin – neurotoxin. Its medicinal application in USA dated back to year 1981 and in Europe – 1992. Botulinum toxin blocks neuromuscular conductance, i.e. it blocks transmission of acetyl-holin and in neuro muscular presynaptic – this is so called temporary (reversible) local chemodenervation. It does not influence synthesis of acetyl-holin. During 2-6 months neural collaterals are formed so that neuromuscular conductance is reestablished and spasm develops again. Botulinum toxin therapy can become inefficient due to three reasons. First is improper application of the toxin itself, second reason is predominant muscular fibrosis and third is presence of antibodies. Interdisciplinary European group of clinical experts in field of movement disorders and experienced users of Botulinum toxin (BoNT), updated its Consensus on Botulinum toxin application dated 2006. Consensus is based on two types of proof: published works and works based on application praxis. In the first part of consensus, authors have formed tables and collected proof, merging data and experience from 36 institutions in 9 European countries, that include more than 10,000 patients and over 45,000 particular treatments. In second part, graphs of motor development, based on Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS), are updated in such a way to get a graphical representation of how motor disturbances with children with cerebral palsy should be treated. Name of this graph is “CPGraph Treatment Modalities – Gross Motor Function”. Its purpose is to ease communication between parents, therapists and doctors, dealing with reachable motor functions, setting realistic goals and perspectives for children with cerebral palsy.
Downloads
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
